22-30695521-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_030758.4(OSBP2):āc.612C>Gā(p.Phe204Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000295 in 1,459,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_030758.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSBP2 | NM_030758.4 | c.612C>G | p.Phe204Leu | missense_variant | 1/14 | ENST00000332585.11 | NP_110385.1 | |
OSBP2 | NM_001282739.2 | c.612C>G | p.Phe204Leu | missense_variant | 1/14 | NP_001269668.1 | ||
OSBP2 | NM_001282738.2 | c.149+1177C>G | intron_variant | NP_001269667.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSBP2 | ENST00000332585.11 | c.612C>G | p.Phe204Leu | missense_variant | 1/14 | 1 | NM_030758.4 | ENSP00000332576.6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000819 AC: 2AN: 244242Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133484
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1459226Hom.: 0 Cov.: 34 AF XY: 0.0000289 AC XY: 21AN XY: 726002
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.612C>G (p.F204L) alteration is located in exon 1 (coding exon 1) of the OSBP2 gene. This alteration results from a C to G substitution at nucleotide position 612, causing the phenylalanine (F) at amino acid position 204 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at